menu
    • menu

    Company profile for Zentiva

    NEW Drugs in Dev: 4
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    Topscience Biotech is a one-stop supplier of sodium hyaluronate//drug manufacturing license, CEP, GMP, DMF, and Form 41 certifications.

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    At present there are 50 markets with a total population of more than a billion people. Zentiva holds leading positions in a number of countries, eg. On markets in the Czech Republic, Romania and Turkey, a pharmaceutical leader. In addition, successfully expanding to other international markets. The key to success is strong and good relations with important trading partners, doctors, pharmacies and patients. Zentiva plans to p...
    At present there are 50 markets with a total population of more than a billion people. Zentiva holds leading positions in a number of countries, eg. On markets in the Czech Republic, Romania and Turkey, a pharmaceutical leader. In addition, successfully expanding to other international markets. The key to success is strong and good relations with important trading partners, doctors, pharmacies and patients. Zentiva plans to provide generic products and also provide access to a range of educational and support programs. The product portfolio covers a wide range of major therapeutic areas.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ZentivaCzechRepublic Flag
    Country
    Country
    Czech Republic
    Address
    Address
    U kabelovny 529/16, Dolni Mecholupy 102 00 Prague 10
    Telephone
    Telephone
    +420 267 241 111
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.zentiva.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/zentiva/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Zentiva Appeals EU Court Decision On Urban Wastewater Directive
    Zentiva Appeals EU Court Decision On Urban Wastewater Directive

    27 Apr 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/zentiva-appeals-eu-court-decision-on-urban-wastewater-directive-302754396.html

    PR NEWSWIRE
    27 Apr 2026
    Share Share
    GTCR Acquires Zentiva, Top European Generics Pharma Company
    GTCR Acquires Zentiva, Top European Generics Pharma Company

    09 Apr 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/gtcr-completes-acquisition-of-zentiva-a-leading-european-generics-pharmaceutical-company-302737491.html

    PR NEWSWIRE
    09 Apr 2026
    Share Share
    Zentiva Releases 2025 ESG-Focused Sustainability Report
    Zentiva Releases 2025 ESG-Focused Sustainability Report

    16 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/zentiva-publishes-2025-sustainability-report-reinforcing-commitment-to-people-partners-and-the-planet-302714495.html

    PR NEWSWIRE
    16 Mar 2026
    Share Share
    Zentiva Urges EU Stop-The-Clock On UWWTD To Safeguard Medicine
    Zentiva Urges EU Stop-The-Clock On UWWTD To Safeguard Medicine

    23 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/zentiva-demands-eulevel-stoptheclock-on-the-uwwtd-to-protect-medicine-availability-302694497.html

    PR NEWSWIRE
    23 Feb 2026
    Share Share
    Zentiva Enters EU Biologics Market with First Biosimilar
    Zentiva Enters EU Biologics Market with First Biosimilar

    01 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/zentiva-expands-into-biologics-with-the-eu-wide-launch-of-its-first-biosimilar-302628251.html

    PR NEWSWIRE
    01 Dec 2025
    Share Share
    Zentiva Earns ESG Transparency Award 2025
    Zentiva Earns ESG Transparency Award 2025

    28 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/demonstrating-accountability-zentiva-receives-prestigious-esg-transparency-award-2025-302628149.html

    PR NEWSWIRE
    28 Nov 2025
    Share Share

    ALL APIs

    read-moreClick the button for full data set
    read-moreClick the button for full data set

    01

    Articaine Hydrochloride

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    PEGS Boston Summit
    Not Confirmed
    arrow

    Articaine Hydrochloride

    Czech Republic

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down Click Us! arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2013-01-31

    Pay. Date : 2013-01-03

    DMF Number : 20287

    Submission : 2007-02-20

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2002-060 - Rev 07

    Issue Date : 2022-05-17

    Type : Chemical

    Substance Number : 1688

    Status : Valid

     JDMF EU-WCarrow-down
    ✖

    Date of Issue : 2023-03-11

    Valid Till : 2026-10-14

    Written Confirmation Number : WC-0133

    Address of the Firm :

    NDC KDMF VMF Others AUDIT arrow-down
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Glibenclamide

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    PEGS Boston Summit
    Not Confirmed
    arrow

    Glibenclamide

    Czech Republic

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 18018

    Submission : 2005-01-21

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2003-223 - Rev 07

    Issue Date : 2022-02-08

    Type : Chemical

    Substance Number : 718

    Status : Valid

     JDMF EU-WCarrow-down
    ✖

    Date of Issue : 2023-03-11

    Valid Till : 2026-10-14

    Written Confirmation Number : WC-0133

    Address of the Firm :

    NDC KDMF VMF Others AUDIT arrow-down
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Pentoxifylline

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    PEGS Boston Summit
    Not Confirmed
    arrow

    Pentoxifylline

    Czech Republic

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF Inactive-api
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 10374

    Submission : 1993-07-21

    Status : Inactive

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2008-012 - Rev 04

    Issue Date : 2022-05-06

    Type : Chemical

    Substance Number : 851

    Status : Valid

     JDMF EU-WCarrow-down
    ✖

    Date of Issue : 2023-03-11

    Valid Till : 2026-10-14

    Written Confirmation Number : WC-0133

    Address of the Firm :

    NDC KDMF arrow-down
    ✖

    Registrant Name : Handok Co., Ltd.

    Registration Date : 2021-04-16

    Registration Number : 20210416-209-J-939

    Manufacturer Name : Zentiva Private Limited@BAKUL PHARMA PRIVATE LIMITED@Bajaj Healthcare Limited (Unit-2)

    Manufacturer Address : Plot No. 3501 to 3515, 6301 to 6313 & 16 meter road/c, GIDC Estate, Ankleshwar – 393 002, Dist. Bharuch, Gujarat State, India@Plot No. 6202, GIDC, City : Ankleshwar-393 002, Dist : Bharuch, Gujarat state, India@Block No. 588, Savli Karachia Road, At & Post - Gothada, Tal-Savli, Dist - Vadodara - 391 776, India

     VMF Others AUDIT arrow-down
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    Tamsulosin

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    PEGS Boston Summit
    Not Confirmed
    arrow

    Tamsulosin

    Czech Republic

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF Inactive-api
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 18186

    Submission : 2005-03-14

    Status : Inactive

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2009-121 - Rev 02

    Issue Date : 2021-12-14

    Type : Chemical

    Substance Number : 2131

    Status : Valid

     JDMF EU-WCarrow-down
    ✖

    Date of Issue : 2023-03-11

    Valid Till : 2026-10-14

    Written Confirmation Number : WC-0133

    Address of the Firm :

    NDC KDMF VMF Others AUDIT arrow-down
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    05

    Agomelatine

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    PEGS Boston Summit
    Not Confirmed
    arrow

    Agomelatine

    Czech Republic

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF CEP/COS JDMF EU-WCarrow-down
    ✖

    Date of Issue : 2023-03-11

    Valid Till : 2026-10-14

    Written Confirmation Number : WC-0133

    Address of the Firm :

    NDC KDMF VMF Others AUDIT arrow-down
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    06

    Glibenclamide

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    PEGS Boston Summit
    Not Confirmed
    arrow

    Glibenclamide

    Czech Republic

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF CEP/COS JDMF EU-WCarrow-down
    ✖

    Date of Issue : 2023-03-11

    Valid Till : 2026-10-14

    Written Confirmation Number : WC-0133

    Address of the Firm :

    NDC KDMF VMF Others AUDIT arrow-down
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    07

    Piretanide

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    PEGS Boston Summit
    Not Confirmed
    arrow

    Piretanide

    Czech Republic

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2024-234 - Rev 01

    Issue Date : 2025-12-18

    Type : Chemical

    Substance Number : 1556

    Status : Valid

     JDMF EU-WC NDC KDMF VMF Others AUDIT arrow-down
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    08

    Ramipril

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    PEGS Boston Summit
    Not Confirmed
    arrow

    Ramipril

    Czech Republic

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF CEP/COS JDMF EU-WCarrow-down
    ✖

    Date of Issue : 2023-03-11

    Valid Till : 2026-10-14

    Written Confirmation Number : WC-0133

    Address of the Firm :

    NDC KDMF VMF Others AUDIT arrow-down
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    09

    Rilmenidine Phosphate

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    PEGS Boston Summit
    Not Confirmed
    arrow

    Rilmenidine Phosphate

    Czech Republic

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2023-124 - Rev 01

    Issue Date : 2026-01-19

    Type : Chemical

    Substance Number : 2020

    Status : Valid

     JDMF EU-WC NDC KDMF VMF Others AUDIT arrow-down
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    10

    Tamsulosin

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    PEGS Boston Summit
    Not Confirmed
    arrow

    Tamsulosin

    Czech Republic

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2023-469 - Rev 01

    Issue Date : 2026-01-19

    Type : Chemical

    Substance Number : 2131

    Status : Valid

     JDMF EU-WC NDC KDMF VMF Others AUDIT arrow-down
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Drugs in Development

    read-more
    read-more
    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    A Clinical Study Comparing Ankle Swelling Caused by Two Different Blood Pressure Medications, Levamlodipine and Amlodipine, in Post-menopausal Women Wit...

    Details:

    Levamlodipine is a small molecule drug, which is currently being evaluated in Phase III clinical studies for the treatment of hypertension.


    Lead Product(s): Levoamlodipine

    Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Undisclosed

    Study Phase: Phase IIIProduct Type: Miscellaneous

    Sponsor: Undisclosed

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable June 01, 2026

    blank

    01

    Zentiva

    Czech Republic
    arrow
    PEGS Boston Summit
    Not Confirmed

    Zentiva

    Czech Republic
    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Levoamlodipine

    Therapeutic Area : Cardiology/Vascular Diseases

    Highest Development Status : Phase III

    Partner/Sponsor/Collaborator : Undisclosed

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    A Clinical Study Comparing Ankle Swelling Caused by Two Different Blood Pressure Medications, Leva...

    Details : Levamlodipine is a small molecule drug, which is currently being evaluated in Phase III clinical studies for the treatment of hypertension.

    Product Name : Undisclosed

    Product Type : Miscellaneous

    Upfront Cash : Inapplicable

    June 01, 2026

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Deals
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    GTCR Acquires Zentiva, Top European Generics Pharma Company

    Details:

    Under the acquisition, Methylphenidate HCl, a small molecule product targeting Dopamine transporter and Norepinephrine transporter, will advance treatment for Attention Deficit Disorder with Hyperactivity.


    Lead Product(s): Methylphenidate Hydrochloride

    Therapeutic Area: Psychiatry/Psychology Brand Name: Affenid XL

    Study Phase: Approved FDFProduct Type: Controlled Substance

    Sponsor: GTCR

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Acquisition April 09, 2026

    blank

    02

    Zentiva

    Czech Republic
    arrow
    PEGS Boston Summit
    Not Confirmed

    Zentiva

    Czech Republic
    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Methylphenidate Hydrochloride

    Therapeutic Area : Psychiatry/Psychology

    Highest Development Status : Approved FDF

    Partner/Sponsor/Collaborator : GTCR

    Deal Size : Undisclosed

    Deal Type : Acquisition

    DEALS_DEV arrow-down

    GTCR Acquires Zentiva, Top European Generics Pharma Company

    Details : Under the acquisition, Methylphenidate HCl, a small molecule product targeting Dopamine transporter and Norepinephrine transporter, will advance treatment for Attention Deficit Disorder with Hyperactivity.

    Product Name : Affenid XL

    Product Type : Controlled Substance

    Upfront Cash : Undisclosed

    April 09, 2026

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Clinical Trial On The Effect Of Artisterol On Risk Factors In Individuals With Suboptimal Cholesterol Levels

    Details:

    Phytosterol is a plant extract/herbal drug, which is currently being evaluated in clinical studies for the treatment of hyperlipoproteinemias.


    Lead Product(s): Phytosterols,Artichoke Extract,Vitamin B1

    Therapeutic Area: Endocrinology Brand Name: Undisclosed

    Study Phase: UndisclosedProduct Type: Plant Extract/Herbal

    Sponsor: Undisclosed

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable February 12, 2026

    blank

    03

    Zentiva

    Czech Republic
    arrow
    PEGS Boston Summit
    Not Confirmed

    Zentiva

    Czech Republic
    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Phytosterols,Artichoke Extract,Vitamin B1

    Therapeutic Area : Endocrinology

    Highest Development Status : Undisclosed

    Partner/Sponsor/Collaborator : Undisclosed

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Clinical Trial On The Effect Of Artisterol On Risk Factors In Individuals With Suboptimal Choleste...

    Details : Phytosterol is a plant extract/herbal drug, which is currently being evaluated in clinical studies for the treatment of hyperlipoproteinemias.

    Product Name : Undisclosed

    Product Type : Plant Extract/Herbal

    Upfront Cash : Inapplicable

    February 12, 2026

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Zentiva Launches First Biosimilar in EU

    Details:

    An antibody, unconjugated, is showing promising results in treating bone conditions.


    Lead Product(s): Undisclosed

    Therapeutic Area: Musculoskeletal Brand Name: Undisclosed

    Study Phase: Approved FDFProduct Type: Antibody, Unconjugated

    Sponsor: Undisclosed

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable December 01, 2025

    blank

    04

    Zentiva

    Czech Republic
    arrow
    PEGS Boston Summit
    Not Confirmed

    Zentiva

    Czech Republic
    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Undisclosed

    Therapeutic Area : Musculoskeletal

    Highest Development Status : Approved FDF

    Partner/Sponsor/Collaborator : Undisclosed

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Zentiva Launches First Biosimilar in EU

    Details : An antibody, unconjugated, is showing promising results in treating bone conditions.

    Product Name : Undisclosed

    Product Type : Antibody, Unconjugated

    Upfront Cash : Inapplicable

    December 01, 2025

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Deals
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Zentiva Announces Sale from Advent to GTCR

    Details:

    GTCR’s acquisition of Zentiva includes its portfolio, ongoing R&D, and pipeline, continuing the company’s expansion of generics and development projects in Europe.


    Lead Product(s): Methylphenidate Hydrochloride

    Therapeutic Area: Psychiatry/Psychology Brand Name: Affenid XL

    Study Phase: Approved FDFProduct Type: Miscellaneous

    Sponsor: GTCR

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Acquisition September 11, 2025

    blank

    05

    Zentiva

    Czech Republic
    arrow
    PEGS Boston Summit
    Not Confirmed

    Zentiva

    Czech Republic
    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Methylphenidate Hydrochloride

    Therapeutic Area : Psychiatry/Psychology

    Highest Development Status : Approved FDF

    Partner/Sponsor/Collaborator : GTCR

    Deal Size : Undisclosed

    Deal Type : Acquisition

    DEALS_DEV arrow-down

    Zentiva Announces Sale from Advent to GTCR

    Details : GTCR’s acquisition of Zentiva includes its portfolio, ongoing R&D, and pipeline, continuing the company’s expansion of generics and development projects in Europe.

    Product Name : Affenid XL

    Product Type : Miscellaneous

    Upfront Cash : Undisclosed

    September 11, 2025

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Deals
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Aurobindo Pharma closing in on $5.5b Zentiva buyout

    Details:

    Zentiva holds a broad portfolio of generic and biosimilar products, including Affenid XL (methylphenidate hydrochloride) for the treatment of Attention-Deficit/Hyperactivity Disorder.


    Lead Product(s): Methylphenidate Hydrochloride

    Therapeutic Area: Psychiatry/Psychology Brand Name: Affenid XL

    Study Phase: Approved FDFProduct Type: Miscellaneous

    Sponsor: Aurobindo Pharma Limited

    Deal Size: $5,500.0 million Upfront Cash: Undisclosed

    Deal Type: Acquisition August 20, 2025

    blank

    06

    Zentiva

    Czech Republic
    arrow
    PEGS Boston Summit
    Not Confirmed

    Zentiva

    Czech Republic
    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Methylphenidate Hydrochloride

    Therapeutic Area : Psychiatry/Psychology

    Highest Development Status : Approved FDF

    Partner/Sponsor/Collaborator : Aurobindo Pharma Limited

    Deal Size : $5,500.0 million

    Deal Type : Acquisition

    DEALS_DEV arrow-down

    Aurobindo Pharma closing in on $5.5b Zentiva buyout

    Details : Zentiva holds a broad portfolio of generic and biosimilar products, including Affenid XL (methylphenidate hydrochloride) for the treatment of Attention-Deficit/Hyperactivity Disorder.

    Product Name : Affenid XL

    Product Type : Miscellaneous

    Upfront Cash : Undisclosed

    August 20, 2025

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Deals
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Zentiva Inks €220M Deal for Former AstraZeneca GI Drug in Europe

    Details:

    Under the licensing agreement, Zentiva will hold the rights for the commercialization and manufacturing of linaprazan glurate, in Europe.


    Lead Product(s): Linaprazan Glurate

    Therapeutic Area: Gastroenterology Brand Name: Undisclosed

    Study Phase: Phase IIProduct Type: Miscellaneous

    Recipient: Cinclus Pharma

    Deal Size: $249.2 million Upfront Cash: $14.7 million

    Deal Type: Licensing Agreement May 22, 2025

    blank

    07

    Zentiva

    Czech Republic
    arrow
    PEGS Boston Summit
    Not Confirmed

    Zentiva

    Czech Republic
    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Linaprazan Glurate

    Therapeutic Area : Gastroenterology

    Highest Development Status : Phase II

    Recipient : Cinclus Pharma

    Deal Size : $249.2 million

    Deal Type : Licensing Agreement

    DEALS_DEV arrow-down

    Zentiva Inks €220M Deal for Former AstraZeneca GI Drug in Europe

    Details : Under the licensing agreement, Zentiva will hold the rights for the commercialization and manufacturing of linaprazan glurate, in Europe.

    Product Name : Undisclosed

    Product Type : Miscellaneous

    Upfront Cash : $14.7 million

    May 22, 2025

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Generic HIV raltegravir medicines approved

    Details:

    Raltegravir is an approved, small molecule, HIV-1 integrase inhibitor, available as a film coated tablet for the treatment of HIV in adult and paediatric patients weighing at least 40kg.


    Lead Product(s): Raltegravir Potassium

    Therapeutic Area: Infections and Infectious Diseases Brand Name: Raltegravir-Generic

    Study Phase: Approved FDFProduct Type: Miscellaneous

    Recipient: Lupin Ltd

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable July 22, 2024

    blank

    08

    Zentiva

    Czech Republic
    arrow
    PEGS Boston Summit
    Not Confirmed

    Zentiva

    Czech Republic
    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Raltegravir Potassium

    Therapeutic Area : Infections and Infectious Diseases

    Highest Development Status : Approved FDF

    Recipient : Lupin Ltd

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Generic HIV raltegravir medicines approved

    Details : Raltegravir is an approved, small molecule, HIV-1 integrase inhibitor, available as a film coated tablet for the treatment of HIV in adult and paediatric patients weighing at least 40kg.

    Product Name : Raltegravir-Generic

    Product Type : Miscellaneous

    Upfront Cash : Inapplicable

    July 22, 2024

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Biocon to Obtain Approval for Diabetes Drug, Liraglutide in UK

    Details:

    Liraglutide-Generic is a glucagon-like peptide-1 (GLP-1) receptor agonist, which is indicated for the treatment of patients with type 2 diabetes mellitus.


    Lead Product(s): Liraglutide

    Therapeutic Area: Endocrinology Brand Name: Liraglutide-Generic

    Study Phase: Approved FDFProduct Type: Peptide, Unconjugated

    Recipient: Biocon

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable March 28, 2024

    blank

    09

    Zentiva

    Czech Republic
    arrow
    PEGS Boston Summit
    Not Confirmed

    Zentiva

    Czech Republic
    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Liraglutide

    Therapeutic Area : Endocrinology

    Highest Development Status : Approved FDF

    Recipient : Biocon

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Biocon to Obtain Approval for Diabetes Drug, Liraglutide in UK

    Details : Liraglutide-Generic is a glucagon-like peptide-1 (GLP-1) receptor agonist, which is indicated for the treatment of patients with type 2 diabetes mellitus.

    Product Name : Liraglutide-Generic

    Product Type : Peptide, Unconjugated

    Upfront Cash : Inapplicable

    March 28, 2024

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Deals
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Zentiva Extends Its Collaboration with Adalvo and Strengthens Its Offering in Respiratory, CNS and Dermatology

    Details:

    Under the terms of collaboration, Zentiva will complement their product offering with the support of longstanding partners Adalvo with new molecules in a variety of therapeutical areas like Respiratory, CNS and Dermatology.


    Lead Product(s): Undisclosed

    Therapeutic Area: Pulmonary/Respiratory Diseases Brand Name: Undisclosed

    Study Phase: UndisclosedProduct Type: Undisclosed

    Recipient: Adalvo

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Expanded Collaboration January 09, 2023

    blank

    10

    Zentiva

    Czech Republic
    arrow
    PEGS Boston Summit
    Not Confirmed

    Zentiva

    Czech Republic
    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Undisclosed

    Therapeutic Area : Pulmonary/Respiratory Diseases

    Highest Development Status : Undisclosed

    Recipient : Adalvo

    Deal Size : Undisclosed

    Deal Type : Expanded Collaboration

    DEALS_DEV arrow-down

    Zentiva Extends Its Collaboration with Adalvo and Strengthens Its Offering in Respiratory, CNS and...

    Details : Under the terms of collaboration, Zentiva will complement their product offering with the support of longstanding partners Adalvo with new molecules in a variety of therapeutical areas like Respiratory, CNS and Dermatology.

    Product Name : Undisclosed

    Product Type : Undisclosed

    Upfront Cash : Undisclosed

    January 09, 2023

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    FDF Dossiers

    read-more
    read-more

    01

    Brand Name : Sertralin Zentiva

    Czech Republic
    PEGS Boston Summit
    Not Confirmed
    arrow

    Brand Name : Sertralin Zentiva

    Czech Republic
    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : Approved

    Registration Country : Sweden

    Sertraline Hydrochloride

    Zentiva

    Dosage Form : Film Coated Tablet

    Brand Name : Sertralin Zentiva

    Dosage Strength : 25mg

    Packaging :

    Approval Date : 06-10-2021

    Application Number : 2.02E+13

    Regulatory Info : Approved

    Registration Country : Sweden

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Brand Name : Sertralin Zentiva

    Czech Republic
    PEGS Boston Summit
    Not Confirmed
    arrow

    Brand Name : Sertralin Zentiva

    Czech Republic
    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : Approved

    Registration Country : Sweden

    Sertraline Hydrochloride

    Zentiva

    Dosage Form : Film Coated Tablet

    Brand Name : Sertralin Zentiva

    Dosage Strength : 50mg

    Packaging :

    Approval Date : 15-05-2024

    Application Number : 2.02E+13

    Regulatory Info : Approved

    Registration Country : Sweden

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Brand Name : Sertralin Zentiva

    Czech Republic
    PEGS Boston Summit
    Not Confirmed
    arrow

    Brand Name : Sertralin Zentiva

    Czech Republic
    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : Approved

    Registration Country : Sweden

    Sertraline Hydrochloride

    Zentiva

    Dosage Form : Film Coated Tablet

    Brand Name : Sertralin Zentiva

    Dosage Strength : 100mg

    Packaging :

    Approval Date : 15-05-2024

    Application Number : 2.02E+13

    Regulatory Info : Approved

    Registration Country : Sweden

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    Brand Name : Abacavir Zentiva

    Czech Republic
    PEGS Boston Summit
    Not Confirmed
    arrow

    Brand Name : Abacavir Zentiva

    Czech Republic
    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : Authorized

    Registration Country : Spain

    Abacavir

    Zentiva

    Dosage Form : Film Coated Tablet

    Brand Name : Abacavir Zentiva

    Dosage Strength : 300MG

    Packaging :

    Approval Date : 30-07-2021

    Application Number : 86115

    Regulatory Info : Authorized

    Registration Country : Spain

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    05

    Brand Name : N/A

    Czech Republic
    PEGS Boston Summit
    Not Confirmed
    arrow

    Brand Name : N/A

    Czech Republic
    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info :

    Registration Country : Czech Republic

    Abacavir Sulfate; Lamivudine

    Zentiva

    Dosage Form : Film Coated Tablet

    Brand Name :

    Dosage Strength : 600MG; 300MG

    Packaging :

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Czech Republic

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    06

    Brand Name : Abacavir/Lamivudine ...

    Czech Republic
    PEGS Boston Summit
    Not Confirmed
    arrow

    Brand Name : Abacavir/Lamivudine ...

    Czech Republic
    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : Deregistered

    Registration Country : Sweden

    Abacavir Sulfate; Lamivudine

    Zentiva

    Dosage Form : Film Coated Tablet

    Brand Name : Abacavir/Lamivudine Zenti...

    Dosage Strength : 600mg;300mg

    Packaging :

    Approval Date : 07-08-2020

    Application Number : 2.02E+13

    Regulatory Info : Deregistered

    Registration Country : Sweden

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    07

    Brand Name : Abiraterone Zentiva

    Czech Republic
    PEGS Boston Summit
    Not Confirmed
    arrow

    Brand Name : Abiraterone Zentiva

    Czech Republic
    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : Prescription

    Registration Country : Estonia

    Abiraterone

    Zentiva

    Dosage Form : Film-Coated Tablet

    Brand Name : Abiraterone Zentiva

    Dosage Strength : 500mg

    Packaging :

    Approval Date :

    Application Number :

    Regulatory Info : Prescription

    Registration Country : Estonia

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    08

    Brand Name : N/A

    Czech Republic
    PEGS Boston Summit
    Not Confirmed
    arrow

    Brand Name : N/A

    Czech Republic
    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info :

    Registration Country : Czech Republic

    Abiraterone Acetate

    Zentiva

    Dosage Form : Film Coated Tablet

    Brand Name :

    Dosage Strength : 500MG

    Packaging :

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Czech Republic

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    09

    Brand Name : Abiraterona Zentiva

    Czech Republic
    PEGS Boston Summit
    Not Confirmed
    arrow

    Brand Name : Abiraterona Zentiva

    Czech Republic
    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : Authorized

    Registration Country : Spain

    Abiraterone Acetate

    Zentiva

    Dosage Form : Tablet

    Brand Name : Abiraterona Zentiva

    Dosage Strength : 250MG

    Packaging :

    Approval Date : 16-03-2021

    Application Number : 85849

    Regulatory Info : Authorized

    Registration Country : Spain

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    10

    Brand Name : Abiraterona Zentiva

    Czech Republic
    PEGS Boston Summit
    Not Confirmed
    arrow

    Brand Name : Abiraterona Zentiva

    Czech Republic
    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : Authorized

    Registration Country : Spain

    Abiraterone Acetate

    Zentiva

    Dosage Form : Film Coated Tablet

    Brand Name : Abiraterona Zentiva

    Dosage Strength : 500MG

    Packaging :

    Approval Date : 16-03-2021

    Application Number : 85850

    Regulatory Info : Authorized

    Registration Country : Spain

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    Inspections and registrations

    Upload your audits for free, ask us

    EDQM

    read-more
    read-more

    01

    GMP Certified

    EU
    PEGS Boston Summit
    Not Confirmed
    arrow

    GMP Certified

    EU
    arrow
    PEGS Boston Summit
    Not Confirmed

    Zentiva

    Type : GMP Certificates

    Number : sukls61217/...

    EudraGMDP Key : 151259

    Country : India

    Issue Date : 2022-08-12

    Post Code : 393002

    NCA Ref : IN-A-ZENO01

    City : Ankleshwar

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    02

    GMP Certified

    EU
    PEGS Boston Summit
    Not Confirmed
    arrow

    GMP Certified

    EU
    arrow
    PEGS Boston Summit
    Not Confirmed

    Zentiva

    Type : GMP Certificates

    Number : DE_HE_01_GM...

    EudraGMDP Key : 147384

    Country : Germany

    Issue Date : 2022-05-10

    Post Code : 65926

    NCA Ref : 165234707397...

    City : Frankfurt Am Main

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    03

    GMP Certified

    EU
    PEGS Boston Summit
    Not Confirmed
    arrow

    GMP Certified

    EU
    arrow
    PEGS Boston Summit
    Not Confirmed

    Zentiva

    Type : GMP Certificates

    Number : DE_HE_01_GM...

    EudraGMDP Key : 142107

    Country : Germany

    Issue Date : 2021-11-29

    Post Code : 65926

    NCA Ref : 00021354

    City : Frankfurt am Main

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    04

    GMP Certified

    EU
    PEGS Boston Summit
    Not Confirmed
    arrow

    GMP Certified

    EU
    arrow
    PEGS Boston Summit
    Not Confirmed

    Zentiva

    Type : GMP Certificates based on a Distant Assessment

    Number : DE_HE_01_GM...

    EudraGMDP Key : 131243

    Country : India

    Issue Date : 2021-06-29

    Post Code : District Bharuch,

    NCA Ref : 00051568

    City : IN-393002, Gujarat

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    05

    GMP Certified

    EU
    PEGS Boston Summit
    Not Confirmed
    arrow

    GMP Certified

    EU
    arrow
    PEGS Boston Summit
    Not Confirmed

    Zentiva

    Type : GMP Certificates

    Number : UK MIA 1778...

    EudraGMDP Key : 53431

    Country : United Kingdom

    Issue Date : 2019-03-27

    Post Code : GU1 4YS

    NCA Ref : 41093-ZENTIV...

    City : GUILDFORD

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    06

    GMP Certified

    EU
    PEGS Boston Summit
    Not Confirmed
    arrow

    GMP Certified

    EU
    arrow
    PEGS Boston Summit
    Not Confirmed

    Zentiva

    Type : GMP Certificates

    Number : 036/2018/RO

    EudraGMDP Key : 51669

    Country : Romania

    Issue Date : 2018-09-19

    Post Code : cod 032266

    NCA Ref : Z1-3

    City : Bucure?ti

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    07

    GMP Certified

    EU
    PEGS Boston Summit
    Not Confirmed
    arrow

    GMP Certified

    EU
    arrow
    PEGS Boston Summit
    Not Confirmed

    Zentiva

    Type : GMP Certificates

    Number : 018/2018/RO

    EudraGMDP Key : 51663

    Country : Romania

    Issue Date : 2018-05-18

    Post Code : cod 032266

    NCA Ref : Z1-3

    City : Bucure?ti

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    08

    GMP Certified

    EU
    PEGS Boston Summit
    Not Confirmed
    arrow

    GMP Certified

    EU
    arrow
    PEGS Boston Summit
    Not Confirmed

    Zentiva

    Type : GMP Certificates

    Number : sukls188197...

    EudraGMDP Key : 34895

    Country : Turkey

    Issue Date : 2016-04-11

    Post Code : 39780

    NCA Ref : 405451461242...

    City : B

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    09

    GMP Certified

    EU
    PEGS Boston Summit
    Not Confirmed
    arrow

    GMP Certified

    EU
    arrow
    PEGS Boston Summit
    Not Confirmed

    Zentiva

    Type : GMP Certificates

    Number : sukls15047/...

    EudraGMDP Key : 1918

    Country : Czech Republic

    Issue Date : 2009-02-13

    Post Code : 584 01

    NCA Ref : 49240030_2

    City : Lede? nad S

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    GDUFA

    read-more
    read-more

    01

    GDUFA fees paid

    USA
    PEGS Boston Summit
    Not Confirmed
    arrow

    GDUFA fees paid

    USA
    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Paid in : 2014

    Zentiva

    API Manufacturer : API MANUFACTURE

    FDF Manufacturer :

    Facility Name : Zentiva

    Business Address : U kabelovny 130 Prague 10237...

    FEI Number : 3004587220

    Country : Czech Republic

    Paid in : 2014

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    ABOUT THIS PAGE

    Contact Zentiva and get a quotation

    Zentiva is a supplier offers 19 products (APIs, Excipients or Intermediates).

    Find Articaine Hydrochloride bulk with DMF, CEP, WC offered by Zentiva

    Find Glibenclamide bulk with DMF, CEP, WC offered by Zentiva

    Find Pentoxifylline bulk with CEP, WC offered by Zentiva

    Find Tamsulosin bulk with CEP, WC offered by Zentiva

    Find Agomelatine bulk with WC offered by Zentiva

    Find Glibenclamide bulk with WC offered by Zentiva

    Find Pheniramine Maleate bulk with WC offered by Zentiva

    Find Piretanide bulk with CEP offered by Zentiva

    Find Ramipril bulk with WC offered by Zentiva

    Find Rilmenidine Phosphate bulk with CEP offered by Zentiva

    Find Tamsulosin bulk with CEP offered by Zentiva

    Find Tenofovir Alafenamide bulk with WC offered by Zentiva

    Find Carvedilol bulk offered by Zentiva

    Find Glimepiride bulk offered by Zentiva

    Find Metipranolol HCl bulk offered by Zentiva

    Find Metoprolol Succinate bulk offered by Zentiva

    Find Tetrahydrozoline bulk offered by Zentiva

    Find Tramadol Hydrochloride bulk offered by Zentiva

    Find Zolpidem Tartrate bulk offered by Zentiva

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search